The concept of metabolic syndrome (MetS) as a cluster of cardiovascular risk factors (obesity, altered glucose metabolism, dyslipidemia, and hypertension) has been around for more than 30 years. It is considered to be the result of complex interactions between centrally located fat, insulin resistance, subclinical inflammation, and other factors in genetically predisposed individuals. MetS diagnosis in adults has been linked to increased risk for cardiovascular disease (CVD) and type 2 diabetes mellitus (T2D). However, MetS in children and adolescents remains a controversial issue despite the extensive research in the field. It is still uncertain which definition should be used for its diagnosis in this age group, what is the clinical significance of such a diagnosis, and how reliably it can predict the future risk of developing CVD and T2D. Even if a child is diagnosed with MetS, management includes addressing each of the syndrome's components individually with weight loss and lifestyle modifications as the basic approach. Co-morbid conditions, such as nonalcoholic fatty liver disease, obstructive sleep apnea, and polycystic ovary syndrome should also be considered. It seems that MetS in children and adolescents should be used clinically as a conceptual framework for the identification of risk factors clustered around obesity and insulin resistance rather than a syndrome that needs to be diagnosed by measuring absolute “all-or-none” criteria.
Get full access to this article
View all access options for this article.
References
1.
CleemanJI. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). J Am Med Assoc, 2001; 285:2486–2497.
2.
MaggeSN, GoodmanE, ArmstrongSC, et al.The metabolic syndrome in children and adolescents: Shifting the focus to cardiometabolic risk factor clustering. Pediatrics, 2017; 140:e20171603
3.
BenthamJ, Di CesareM, BilanoV, et al.Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: A pooled analysis of 2416 population-based measurement studies in 128 · 9 million children, adolescents, and adults. Lancet, 2017; 390:2627–2642.
4.
WittcoppC, ConroyR. Metabolic syndrome in children and adolescents. Pediatr Rev, 2016; 37:193–202.
5.
GepsteinV, WeissR. Obesity as the main risk factor for metabolic syndrome in Children. Front Endocrinol (Lausanne), 2019; 10:568.
6.
HalesCN, BarkerDJP. Type 2 (non-insulin-dependent) diabetes mellitus: The thrifty phenotype hypothesis. Diabetologia, 1992; 35:595–601.
7.
EvagelidouEN, GiaprosVI, ChallaAS, et al.Prothrombotic state, cardiovascular, and metabolic syndrome risk factors in prepubertal children born large for gestational age. Diabetes Care, 2010; 33:2468–2470.
8.
EvagelidouEN, GiaprosVI, ChallaAS, et al.Serum adiponectin levels, insulin resistance, and lipid profile in children born small for gestational age are affected by the severity of growth retardation at birth. Eur J Endocrinol, 2007; 156:271–277.
9.
BusslerS, PenkeM, FlemmingG, et al.Novel insights in the metabolic syndrome in childhood and adolescence. Horm Res Paediatr, 2017; 88:181–193.
10.
ChaitA, BornfeldtKE. Diabetes and atherosclerosis: Is there a role for hyperglycemia?. J Lipid Res, 2009; 50:S335.
11.
GuilhermeA, VirbasiusJV, PuriV, et al.Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol, 2008; 9:367–377.
12.
ModanM, HalkinH, AlmogS, et al.Hyperinsulinemia. A link between hypertension obesity and glucose intolerance. J Clin Invest, 1985; 75:809–817.
13.
DeFronzoRA, FerranniniE. Insulin resistance: A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care, 1991; 14:173–194.
14.
ChandraA, NeelandIJ, BerryJD, et al.The relationship of body mass and fat distribution with incident hypertension: Observations from the Dallas Heart study. J Am Coll Cardiol, 2014; 64:997–1002.
15.
HallJE, Da SilvaAA, Do CarmoJM, et al.Obesity-induced hypertension: Role of sympathetic nervous system, leptin, and melanocortins. J Biol Chem, 2010; 285:17271–17276.
16.
FeigDI, JohnsonRJ. Hyperuricemia in childhood primary hypertension. Hypertension, 2003; 42:247–252.
17.
da SilvaAA, do CarmoJM, LiX, et al.Role of hyperinsulinemia and insulin resistance in hypertension: Metabolic syndrome revisited. Can J Cardiol, 2020; 36:671–682.
18.
DeepaM, FarooqS, DattaM, et al.Prevalence of metabolic syndrome using WHO, ATPIII and IDF definitions in Asian Indians: The Chennai Urban Rural Epidemiology Study (CURES-34). Diabetes Metab Res Rev, 2007; 23:127–134.
19.
AlbertiKGMM, EckelRH, GrundySM, et al.Harmonizing the metabolic syndrome: A joint interim statement of the international diabetes federation task force on epidemiology and prevention; National heart, lung, and blood institute; American Heart Association; World heart federation; International atherosclerosis society; And international association for the study of obesity. Circulation, 2009; 120:1640–1645.
20.
ChenW, SrinivasanSR, ElkasabanyA, et al.Cardiovascular risk factors clustering features of insulin resistance syndrome (Syndrome X) in a biracial (Black-White) population of children, adolescents, and young adults: The Bogalusa Heart Study. Am J Epidemiol, 1999; 150:667–674.
21.
CookS, WeitzmanM, AuingerP, et al.Prevalence of a metabolic syndrome phenotype in adolescents: Findings from the Third National Health and Nutrition Examination Survey, 1988–1994. Arch Pediatr Adolesc Med, 2003; 157:821–827.
22.
CruzML, WeigensbergMJ, HuangTTK, et al.The metabolic syndrome in overweight Hispanic Youth and the Role of Insulin Sensitivity. J Clin Endocrinol Metab, 2004; 89:108–113.
23.
WeissR, DziuraJ, BurgertTS, et al.Obesity and the metabolic syndrome in children and adolescents. N Engl J Med, 2004; 350:2362–2374.
24.
De FerrantiSD, GauvreauK, LudwigDS, et al.Prevalence of the metabolic syndrome in American adolescents: Findings from the Third National Health and Nutrition Examination Survey. Circulation, 2004; 110:2494–2497.
25.
VinerRM, SegalTY, Lichtarowicz-KrynskaE, et al.Prevalence of the insulin resistance syndrome in obesity. Arch Dis Child, 2005; 90:10–14.
26.
AhrensW, MorenoL, MårildS, et al.Metabolic syndrome in young children: Definitions and results of the IDEFICS study. Int J Obes, 2014; 38:S4–S14.
27.
ZimmetP, AlbertiKGM, KaufmanF, et al.The metabolic syndrome in children and adolescents—An IDF consensus report. Pediatr Diabetes, 2007; 8:299–306.
28.
SteinbergerJ, DanielsSR, EckelRH, et al.Progress and challenges in metabolic syndrome in children and adolescents. A Scientific Statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular Nursing; and Council on Nutrition, Physical Activity, and Metabolism. Circulation, 2009; 119:628–647.
29.
ZeitlerP, ArslanianS, FuJ, et al.ISPAD Clinical Practice Consensus Guidelines 2018: Type 2 diabetes mellitus in youth. 2018. Pediatr Diabetes, 2018; 19:28–46.
30.
WeissR, TaksaliSE, TamborlaneWV, et al.Predictors of changes in glucose tolerance status in obese youth. Diabetes Care, 2005; 28:902–909.
31.
SerbisA, GiaprosV, ChallaA, et al.Elevated 1-hour post-load plasma glucose identifies obese youth with abnormal glucose metabolism and an unfavourable inflammatory profile. Clin Endocrinol (Oxf), 2018; 89:757–764.
32.
GusemanEH, EisenmannJC, LaursonKR, et al.Calculating a continuous metabolic syndrome score using nationally representative reference values. Acad Pediatr, 2018; 18:589–592.
33.
HeshmatR, HeidariM, EjtahedHS, et al.Validity of a continuous metabolic syndrome score as an index for modeling metabolic syndrome in children and adolescents: The CASPIAN-V study. Diabetol Metab Syndr, 2017; 9:89.
34.
MagnussenCG, CheriyanS, SabinMA, et al.Continuous and dichotomous metabolic syndrome definitions in youth predict adult type 2 diabetes and carotid artery intima media thickness: The cardiovascular risk in young Finns Study. J Pediatr, 2016; 171:97–103.
35.
KamelM, SmithBT, WahiG, et al.Continuous cardiometabolic risk score definitions in early childhood: A scoping review. Obes Rev, 2018; 19:1688–1699.
36.
LemieuxI, PoirierP, BergeronJ, et al.Hypertriglyceridemic waist: A useful screening phenotype in preventive cardiology?. Can J Cardiol, 2007; 23:23B–31B.
37.
SumnerAE. Ethnic differences in triglyceride levels and high-density lipoprotein lead to underdiagnosis of the metabolic syndrome in black children and adults. J Pediatr, 2009; 155:S7.e7–S7.e11.
EyreE, DuncanM, NevillA. South Asian Children have increased body fat in comparison to white children at the same body mass index. Children, 2017; 4:102.
40.
TominagaK, FujimotoE, SuzukiK, et al.Prevalence of non-alcoholic fatty liver disease in children and relationship to metabolic syndrome, insulin resistance, and waist circumference. Environ Health Prev Med, 2009; 14:142–149.
41.
ClementeMG, MandatoC, PoetaM, et al.Pediatric non-alcoholic fatty liver disease: Recent solutions, unresolved issues, and future research directions. World J Gastroenterol, 2016; 22:8078–8093.
42.
FramnesSN, ArbleDM. The bidirectional relationship between obstructive sleep apnea and metabolic disease. Front Endocrinol (Lausanne), 2018; 9:440.
43.
AndersonAD, SolorzanoCMB, McCartneyCR. Childhood obesity and its impact on the development of adolescent PCOS. Semin Reprod Med, 2014; 32:202–213.
44.
BerensonGS, SrinivasanSR, BaoW, et al.Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. N Engl J Med, 1998; 338:1650–1656.
45.
MalikS, WongND, FranklinSS, et al.Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation, 2004; 110:1245–1250.
46.
MorrisonJA, FriedmanLA, WangP, et al.Metabolic syndrome in childhood predicts adult metabolic syndrome and type 2 diabetes mellitus 25 to 30 years later. J Pediatr, 2008; 152:201–206.
47.
SchubertCM, SunSS, BurnsTL, et al.Predictive ability of childhood metabolic components for adult metabolic syndrome and type 2 diabetes. J Pediatr, 2009; 155:S6.e1–S6.e7.
48.
ChenW, SrinivasanSR, LiS, et al.Metabolic syndrome variables at low levels in childhood are beneficially associated with adulthood cardiovascular risk: The Bogalusa Heart Study. Diabetes Care, 2005; 28:126–131.
49.
ReuterCP, BurgosMS, BarbianCD, et al.Comparison between different criteria for metabolic syndrome in schoolchildren from southern Brazil. Eur J Pediatr, 2018; 177:1471–1477.
50.
GoodmanE, DanielsSR, MeigsJB, et al.Instability in the diagnosis of metabolic syndrome in adolescents. Circulation, 2007; 115:2316–2322.
51.
RajjoT, MohammedK, AlsawasM, et al.Treatment of pediatric obesity: An umbrella systematic review. J Clin Endocrinol Metab, 2017; 102:763–775.
52.
StonerL, BeetsMW, BrazendaleK, et al.Exercise dose and weight loss in adolescents with overweight-obesity: A meta-regression. Sport Med, 2019; 49:83–94.
53.
StyneDM, ArslanianSA, ConnorEL, et al.Pediatric obesity-assessment, treatment, and prevention: An endocrine society clinical practice guideline. J Clin Endocrinol Metab, 2017; 102:709–757.
54.
KellyAS, AuerbachP, Barrientos-PerezM, et al.A randomized, controlled trial of liraglutide for adolescents with obesity. N Engl J Med, 2020; 382:2117–2128.
55.
IngeTH, CourcoulasAP, JenkinsTM, et al.Five-year outcomes of gastric bypass in adolescents as compared with adults. N Engl J Med, 2019; 380:2136–2145.
56.
ReinehrT, KiessW, KapellenT, et al.Insulin sensitivity among obese children and adolescents, according to degree of weight loss. Pediatrics, 2004; 114:1569–1573.
57.
MeyerAA, KundtG, LenschowU, et al.Improvement of early vascular changes and cardiovascular risk factors in obese children after a six-month exercise program. J Am Coll Cardiol, 2006; 48:1865–1870.
58.
KleberM, LassN, PapckeS, et al.One-year follow-up of untreated obese white children and adolescents with impaired glucose tolerance: High conversion rate to normal glucose tolerance. Diabet Med, 2010; 27:516–521.
59.
ValaiyapathiB, SunilB, AshrafAP. Approach to hypertriglyceridemia in the pediatric population. Pediatr Rev, 2017; 38:424–434.
60.
YangQ, ZhangZ, KuklinaEV, et al.Sodium intake and blood pressure among US children and adolescents. Pediatrics, 2012; 130:611–619.
